pBSII-FRT-MCS
(Plasmid
#205988)
-
Purpose(Empty Backbone) Vector containing FRT and FRT-F3 sites
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 205988 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepBluescriptII SK+
-
Modifications to backboneReplaced original multiple cloning site with a variation, containing FRT and FRT-F3 sites for Flp recombinase
-
Vector typePCR vector
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Cloning Information
- Cloning method Restriction Enzyme
- 5′ sequencing primer M13F
- 3′ sequencing primer M13R (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pBSII-FRT-MCS was a gift from Sharon Torigoe (Addgene plasmid # 205988 ; http://n2t.net/addgene:205988 ; RRID:Addgene_205988) -
For your References section:
A suboptimal OCT4-SOX2 binding site facilitates the naive-state specific function of a Klf4 enhancer. Waite JB, Boytz R, Traeger AR, Lind TM, Lumbao-Conradson K, Torigoe SE. PLoS One. 2024 Sep 30;19(9):e0311120. doi: 10.1371/journal.pone.0311120. eCollection 2024. 10.1371/journal.pone.0311120 PubMed 39348365